Achiko AG · ISIN: CH0522213468 · EQS - adhoc news

Achiko AG Production and Sales Update

Achiko AG Production and Sales Update  AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in Indonesia in validation tests. Sample of 20 PCR Positive and 9 Negative samples, indicated a 100% match between AptameX™ Gen 2 product to PCR, whilst Clungene and Abbott’s Pan Bio were between 6% and 50% sensitive only. Achiko remains committed to sales and is resolving production issues. Zurich, 21 December 2022: Ad hoc announcement pursuant to Art. 53 LR –...
About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Achiko AG

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (1)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
21 December 2022 06:45AM
Achiko AG Production and Sales Update
CH0522213468
Achiko AG Production and Sales Update  AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in Indonesia in validation tests. Sample of 20 PCR Positive and 9 Negative samples, indicated a 100% match between AptameX™ Gen 2 product to PCR, whilst Clungene and Abbott’s Pan Bio were between 6% and 50% sensiti...
Achiko AG
About the publication
21 December 2022 06:45AM
Achiko AG Production and Sales Update
CH0522213468
Achiko AG Production and Sales Update  AptameX™ Gen 2 Covid-19 rapid calibration outperforms Abbott Pan Bio and Clugene’s rapid tests in Indonesia in validation tests. Sample of 20 PCR Positive and 9 Negative samples, indicated a 100% match between AptameX™ Gen 2 product to PCR, whilst Clungene and Abbott’s Pan Bio were between 6% and 50% sensiti...
Achiko AG
About the publication
20 December 2022 06:00PM
Shareholders adopt all proposals
CH0522213468
Achiko AG / Key word(s): AGMEGM 2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders adopt all proposals 20.12.2022 / 18:00 CET/CEST 2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders adopt all proposals Zurich, 20 December 2022: Corporate News – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Ach...
Achiko AG
About the publication
20 December 2022 06:00PM
Shareholders adopt all proposals
CH0522213468
Achiko AG / Key word(s): AGMEGM 2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders adopt all proposals 20.12.2022 / 18:00 CET/CEST 2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders adopt all proposals Zurich, 20 December 2022: Corporate News – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Ach...
Achiko AG
About the publication
25 November 2022 06:10PM
Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022
CH0522213468
 Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022 Zurich, 25 November 2022: Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) has issued a convocation notice to its shareholders for the Company's Annual General Meeting taking place at 10:00 a.m. (CET) on 2...
Achiko AG
About the publication
25 November 2022 06:10PM
Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022
CH0522213468
 Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022 Zurich, 25 November 2022: Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) has issued a convocation notice to its shareholders for the Company's Annual General Meeting taking place at 10:00 a.m. (CET) on 2...
Achiko AG
About the publication
17 November 2022 04:10PM
Achiko AG Announces Corporate Update Webcast
CH0522213468
Achiko AG / Key word(s): Miscellaneous Achiko AG Announces Corporate Update Webcast 17.11.2022 / 16:10 CET/CEST  Achiko AG Announces Corporate Update Webcast Commercial Delivery of its Saliva-Based Covid-19 Test AptameXTM Has Commenced REPLACES MEDIA RELEASE “ACHIKO AG ANNOUNCES CORPORATE UPDATE WEBCAST” FROM 16 NOVEMBER 2022, ...
Achiko AG
About the publication
17 November 2022 04:10PM
Achiko AG Announces Corporate Update Webcast
CH0522213468
Achiko AG / Key word(s): Miscellaneous Achiko AG Announces Corporate Update Webcast 17.11.2022 / 16:10 CET/CEST  Achiko AG Announces Corporate Update Webcast Commercial Delivery of its Saliva-Based Covid-19 Test AptameXTM Has Commenced REPLACES MEDIA RELEASE “ACHIKO AG ANNOUNCES CORPORATE UPDATE WEBCAST” FROM 16 NOVEMBER 2022, ...
Achiko AG
About the publication
16 November 2022 04:20PM
Achiko AG Announces Corporate Update Webcast
CH0522213468
Achiko AG / Key word(s): Miscellaneous Achiko AG Announces Corporate Update Webcast 16.11.2022 / 16:20 CET/CEST  Achiko AG Announces Corporate Update Webcast Commercial Delivery of its Saliva-Based Covid-19 Test AptameXTM Has Commenced Zurich, 16 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; ...
Achiko AG
About the publication
16 November 2022 04:20PM
Achiko AG Announces Corporate Update Webcast
CH0522213468
Achiko AG / Key word(s): Miscellaneous Achiko AG Announces Corporate Update Webcast 16.11.2022 / 16:20 CET/CEST  Achiko AG Announces Corporate Update Webcast Commercial Delivery of its Saliva-Based Covid-19 Test AptameXTM Has Commenced Zurich, 16 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; ...
Achiko AG
About the publication
14 November 2022 06:45AM
Achiko AG Commences Commercial Deliveries in Indonesia
CH0522213468
 Achiko AG Commences Commercial Deliveries in Indonesia  Commencing Commercial Deliveries of its Generation 2 AptameXTM Covid-19 tests kits with Nahdlatul Ulama DKI in Jakarta, Indonesia Zurich, 14 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) is proud ...
Achiko AG
About the publication
14 November 2022 06:45AM
Achiko AG Commences Commercial Deliveries in Indonesia
CH0522213468
 Achiko AG Commences Commercial Deliveries in Indonesia  Commencing Commercial Deliveries of its Generation 2 AptameXTM Covid-19 tests kits with Nahdlatul Ulama DKI in Jakarta, Indonesia Zurich, 14 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) is proud ...
Achiko AG
About the publication
02 November 2022 06:45AM
Achiko AG Production and Company Update
CH0522213468
Achiko AG Production and Company Update  Completing Production Pilot for Generation 2 of AptameXTM as a Precursor to Mass Commercial Production Expect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of Mass Production Zurich, 2 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: AC...
Achiko AG
About the publication
02 November 2022 06:45AM
Achiko AG Production and Company Update
CH0522213468
Achiko AG Production and Company Update  Completing Production Pilot for Generation 2 of AptameXTM as a Precursor to Mass Commercial Production Expect to Commence Delivery to Sales and Marketing Contract with Nahdlatul Ulama on Commencement of Mass Production Zurich, 2 November 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: AC...
Achiko AG
About the publication
07 October 2022 06:45AM
Achiko AG Appoints New Chief Financial Officer
CH0522213468
 Achiko AG Appoints New Chief Financial Officer Zurich, 7 October 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) a healthcare technology company that is developing new innovations and disruptive diagnostic solutions that put people first announced that it has app...
Achiko AG
About the publication
07 October 2022 06:45AM
Achiko AG Appoints New Chief Financial Officer
CH0522213468
 Achiko AG Appoints New Chief Financial Officer Zurich, 7 October 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) a healthcare technology company that is developing new innovations and disruptive diagnostic solutions that put people first announced that it has app...
Achiko AG
About the publication
03 October 2022 03:05AM
Achiko AG reports first half to 30 June 2022 results and provides corporate update as of 30 September 2022
CH0522213468
 Achiko AG reports first half to 30 June 2022 results and provides corporate update as of 30 September 2022 Achiko reports an EBITDA loss of USD 1.9 million, compared to an EBITDA loss of USD 4.6 million for the 6 months ending 30 June 2021. Focal points of the first half year were completion of a major new sales contract in Indonesia, obtaining ...
Achiko AG
About the publication
03 October 2022 03:05AM
Achiko AG reports first half to 30 June 2022 results and provides corporate update as of 30 September 2022
CH0522213468
 Achiko AG reports first half to 30 June 2022 results and provides corporate update as of 30 September 2022 Achiko reports an EBITDA loss of USD 1.9 million, compared to an EBITDA loss of USD 4.6 million for the 6 months ending 30 June 2021. Focal points of the first half year were completion of a major new sales contract in Indonesia, obtaining ...
Achiko AG
About the publication
06 September 2022 06:45AM
Achiko AG Corporate and Operational Update
CH0522213468
Achiko AG Corporate and Operational Update  ACHI shares resumed trading on SIX Swiss Exchange on 1 September after successful completion of Audit and Financing Key Swiss investors provide CHF 1.3 million via convertible notes Successful calibration of Generation 2 AptameX™ product Steven Goh, CEO, to step down upon appointment of successor Zur...
Achiko AG
About the publication
06 September 2022 06:45AM
Achiko AG Corporate and Operational Update
CH0522213468
Achiko AG Corporate and Operational Update  ACHI shares resumed trading on SIX Swiss Exchange on 1 September after successful completion of Audit and Financing Key Swiss investors provide CHF 1.3 million via convertible notes Successful calibration of Generation 2 AptameX™ product Steven Goh, CEO, to step down upon appointment of successor Zur...
Achiko AG
About the publication
31 August 2022 11:55PM
Achiko AG Announces Newly Published Annual Report and Accounts for the Year Ended 31 December 2021
CH0522213468
Achiko AG Announces Newly Published Annual Report and Accounts for the Year Ended 31 December 2021 Zurich, 31 August 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces its financial results for the year ended 31 December 2021. On 9 August 2022, the Company...
Achiko AG
About the publication
31 August 2022 11:55PM
Achiko AG Announces Newly Published Annual Report and Accounts for the Year Ended 31 December 2021
CH0522213468
Achiko AG Announces Newly Published Annual Report and Accounts for the Year Ended 31 December 2021 Zurich, 31 August 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces its financial results for the year ended 31 December 2021. On 9 August 2022, the Company...
Achiko AG
About the publication
09 August 2022 07:05AM
Achiko AG – Achiko to publish its 2021 Annual Report by 31 August 2022
CH0522213468
Achiko AG – Achiko to publish its 2021 Annual Report by 31 August 2022 Zurich, 9 August 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its 2021 annual report on 31 August 2022 at the latest.  Achiko has published its 2021 annua...
Achiko AG
About the publication
09 August 2022 07:05AM
Achiko AG – Achiko to publish its 2021 Annual Report by 31 August 2022
CH0522213468
Achiko AG – Achiko to publish its 2021 Annual Report by 31 August 2022 Zurich, 9 August 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its 2021 annual report on 31 August 2022 at the latest.  Achiko has published its 2021 annua...
Achiko AG
About the publication
07 July 2022 07:45PM
Achiko AG – Investor Briefing
CH0522213468
Achiko AG / Key word(s): Miscellaneous Achiko AG – Investor Briefing 07.07.2022 / 19:45 Achiko AG – Investor Briefing Zurich, 7 July 2022:  Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), would like to invite investors and shareholders to a moderated investor call. A powerpoint presentation wil...
Achiko AG
About the publication
07 July 2022 07:45PM
Achiko AG – Investor Briefing
CH0522213468
Achiko AG / Key word(s): Miscellaneous Achiko AG – Investor Briefing 07.07.2022 / 19:45 Achiko AG – Investor Briefing Zurich, 7 July 2022:  Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”), would like to invite investors and shareholders to a moderated investor call. A powerpoint presentation wil...
Achiko AG
About the publication
28 June 2022 06:55AM
Achiko AG – Suspension of Trading
CH0522213468
Achiko AG – Suspension of Trading Zurich, 28 June 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that it has received notification from SIX Exchange Regulation AG {“SER”) that the trading of Achiko’s shares shall be suspended as of Tuesday, 28 June 2022...
Achiko AG
About the publication
28 June 2022 06:55AM
Achiko AG – Suspension of Trading
CH0522213468
Achiko AG – Suspension of Trading Zurich, 28 June 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that it has received notification from SIX Exchange Regulation AG {“SER”) that the trading of Achiko’s shares shall be suspended as of Tuesday, 28 June 2022...
Achiko AG
About the publication
26 June 2022 11:55PM
Achiko AG Announces Annual Results for the Year Ended 31 December 2021
CH0522213468
  Achiko AG Announces Annual Results for the Year Ended 31 December 2021 Zurich, 26 June 2022– Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces its financial results for the year ended 31 December 2021, and progress since then. For the year ended 31 December 2021, the Group recorded a net loss of USD $9...
Achiko AG
About the publication
26 June 2022 11:55PM
Achiko AG Announces Annual Results for the Year Ended 31 December 2021
CH0522213468
  Achiko AG Announces Annual Results for the Year Ended 31 December 2021 Zurich, 26 June 2022– Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces its financial results for the year ended 31 December 2021, and progress since then. For the year ended 31 December 2021, the Group recorded a net loss of USD $9...
Achiko AG
About the publication
20 June 2022 11:20PM
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 26 June 2022
CH0522213468
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 26 June 2022  Zurich, 20 June 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the...
Achiko AG
About the publication
10 June 2022 11:15PM
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 20 June 2022
CH0522213468
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 20 June 2022  Zurich, 10 June 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the...
Achiko AG
About the publication
06 June 2022 11:05AM
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 10 June 2022
CH0522213468
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 10 June 2022 Zurich, 6 June 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the ye...
Achiko AG
About the publication
31 May 2022 06:45AM
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 6 June 2022
CH0522213468
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by 6 June 2022 Zurich, 31 May 2022: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the yea...
Achiko AG
About the publication
25 May 2022 06:45AM
Achiko AG Secures CHF 1.25 million Financing with Strategic Investors Buranto AG and Negma Group
CH0522213468
Achiko AG Secures CHF 1.25 million Financing with Strategic Investors Buranto AG and Negma Group - Buranto AG provided a CHF 250,000 loan facility and existing strategic investor Negma Group provided a CHF 1.0 million loan facility - Derek Brandt, co-owner of Buranto AG, joins Achiko’s Advisory Board - Funds to be used for production in Indones...
Achiko AG
About the publication
19 May 2022 08:26AM
Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 December 2021
CH0522213468
Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 December 2021 - Full year unaudited adjusted EBITDA loss [corrected] of USD$5,272,179 (2020: USD$8,728,709 loss) following 6 months unaudited loss of USD$3,915,136 to 30 June 2021 and closing Shareholders Equity of USD($4,297,969) (2020: USD$4,052,073). - Restructuring of th...
Achiko AG
About the publication
19 May 2022 06:45AM
Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 December 2021
CH0522213468
Achiko AG Reports Key Unaudited Financial Results for the Year Ended 31 December 2021 - Full year unaudited adjusted EBITDA of USD$5,272,179 (2020: USD$8,728,709) following 6 months unaudited of USD$3,915,136 to 30 June 2021 and closing Shareholders Equity of USD$4,297,969 (2020: $4,052,073). - Restructuring of the European operations in mid-202...
Achiko AG
About the publication
17 May 2022 06:45AM
Achiko AG Obtains CE Mark for AptameXTM Covid-19 Rapid Test
CH0522213468
Achiko AG Obtains CE Mark for AptameXTM Covid-19 Rapid Test - Registered AptameX and has obtained a CE Mark, allowing the product to be sold in 27 countries in the EU - AptameX has unique performance advantages over other rapid tests through its use of DNA aptamers - The Company expects to have AptameX in widespread commercial availability in Q...
Achiko AG
About the publication
29 April 2022 06:45AM
Achiko AG - Publication of Annual Report and Annual Financial Statements 2021 to Occur by 31 May 2022
CH0522213468
Achiko AG - Publication of Annual Report and Annual Financial Statements 2021 to Occur by 31 May 2022 Zurich, 29 April 2022: Ad hoc announcement pursuant to Art. 53 LR - Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) ("Achiko", the "Company") announces that Achiko will publish its annual report and its annual financial statements for the y...
Achiko AG
About the publication
28 April 2022 06:45AM
AptameX Production and Commercialisation Update
CH0522213468
AptameX Production and Commercialisation Update - Company has commenced shipping and will book first sales in May 2022 - Reorganised production line able to meet stronger than expected demand for Achiko AG's innovative DNA aptamer saliva-based rapid test for Covid-19 - Validated calibration through quality control tests completed in Taiwan and ...
Achiko AG
About the publication
20 April 2022 10:00AM
Achiko AG Signs Major Marketing and Sales Agreement with the World's Largest Islamic Association for its AptameX Covid-19 rapid test
CH0522213468
Achiko AG Signs Major Marketing and Sales Agreement with the World's Largest Islamic Association for its AptameX Covid-19 rapid test   Signed major deal with Pengurus Wilayah Nahdlatul Ulama DKI Jakarta, for the use of Covid-19 test AptameX in general assemblies and activities. Located primarily in Indonesia, Nahdlatul Ulama is the world's larges...
Achiko AG
About the publication
20 April 2022 09:45AM
Achiko secures up to CHF12m equity and debt financing lines with RiverFort over 3 years
CH0522213468
Achiko secures up to CHF12m equity and debt financing lines with RiverFort over 3 years Zurich, 20 April 2022: Ad hoc announcement pursuant to Art. 53 LR - Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) ("Achiko", the "Company") announces the completion of an Equity Subscription Agreement ("ESS") with the institutional investor RiverFort G...
Achiko AG
About the publication
03 March 2022 06:45AM
Achiko AG Production and Sales Update
CH0522213468
  Achiko AG Production and Sales Update - Unique chemistry with DNA Aptamers Completing pre-sales validation testing - Completing pre-sales validation testing in Indonesia Zurich, 3 March 2022: Ad hoc announcement pursuant to Art. 53 LR - Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) ("Achiko", the "Company") today announced an update ...
Achiko AG
About the publication
14 February 2022 06:45AM
Achiko AG Research Paper and Commercialisation Update
CH0522213468
Achiko AG Research Paper and Commercialisation Update - Calibration study results now available in draft paper on medRxiv, a preprint platform for health sciences, as "DNA Aptamer Gold Nanoparticle Colorimetric Diagnostic Test Kit of Saliva Samples for SARS-CoV-2 Virus Linked to Mobile Phone Application" - AptameX is the world's first scale appl...
Achiko AG
About the publication
27 January 2022 06:45AM
Achiko AG strengthens senior team with appointment of Head of Corporate Development
CH0522213468
Achiko AG strengthens senior team with appointment of Head of Corporate Development - Achiko AG appoints David Hodge to the role of Head of Corporate Development in Switzerland - David Hodge will oversee Corporate Affairs, and Strategic and Corporate Development - Board Director Christophe Laurent to retire at month end Zurich, 27 January 2022...
Achiko AG
About the publication
17 January 2022 02:08PM
Achiko AG Announces Feature Article on How We Get Back to Normal with its AptameXTM Covid-19 Rapid Test Technology
CH0522213468
EQS-News: Achiko AG / Key word(s): Miscellaneous Achiko AG Announces Feature Article on How We Get Back to Normal with its AptameXTM Covid-19 Rapid Test Technology 17.01.2022 / 14:08 Achiko AG Announces Feature Article on How We Get Back to Normal with its AptameXTM Covid-19 Rapid Test Technology Zurich, 17 January 2022- Achiko...
Achiko AG
About the publication
14 January 2022 07:31AM
Achiko AG Reports Breakthrough Calibration Results for AptameX Covid-19 Rapid Test Technology
CH0522213468
Achiko AG Reports Breakthrough Calibration Results for AptameX Covid-19 Rapid Test Technology - AptameX(TM) Covid-19 rapid calibration successfully classified 100% of results indicating a likely > 97% Sensitivity and > 97% Specificity result in the first-generation test kits. - Results were demonstrable both at CT values under 25, and betwe...
Achiko AG
About the publication
31 December 2021 06:45AM
Achiko AG completing CHF4.85m financing and changes to senior team
CH0522213468
Achiko AG completing CHF4.85m financing and changes to senior team - Completing CHF 4.85 million placement from August 2021 - Board Director Christophe Laurent to retire - Appoints Adam O'Keeffe as ad interim Chief Financial Officer Zurich, 31 December 2021: Ad hoc announcement pursuant to Art. 53 LR - Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN ...
Achiko AG
About the publication
More Achiko AG related information
Type Total Last Made by Go to
Corporate Research 1 30th September 2020 EQS Group AG Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN